Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Anne Dockery, from Southville, Bristol, took up running at the age of 52 and began competing in triathlons in her 60s. Her ...

This summer, communities throughout the country are experiencing periods of intense heat, and there’s more to come.

The CAAT governance board recommends transitioning from the COPD Assessment Test to the CAAT and using it for patients with ...

Merck to acquire respiratory drug maker, Verona Pharma for $10 billion: Rahway, New Jersey Thursday, July 10, 2025, 09:00 Hrs [IST] Merck, known as MSD outside of the United State ...

Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the ...

Scientists have discovered a previously unrecognized way that human airways protect lungs from infection—through the action of cilia, tiny hair-like structures lining the respiratory tract.